Abstract
The HIV-1 capsid is a fullerene cone made of quasi-equivalent hexamers and pentamers of the viral CA protein. Typically, quasi-equivalent assembly of viral capsid subunits is controlled by a molecular switch. Here, we identify a Thr-Val-Gly-Gly motif that modulates CA hexamer/pentamer switching by folding into a 310 helix in the pentamer and random coil in the hexamer. Manipulating the coil/helix configuration of the motif allowed us to control pentamer and hexamer formation in a predictable manner, thus proving its function as a molecular switch. Importantly, the switch also remodels the common binding site for host factors that are critical for viral replication and the new ultra-potent HIV-1 inhibitor lenacapavir. This study reveals that a critical assembly element also modulates the post-assembly and viral replication functions of the HIV-1 capsid and provides new insights on capsid function and inhibition.
Subject terms: Virology, Cryoelectron microscopy, Supramolecular assembly, Structure determination
The authors use single-particle cryo-EM to analyze the fullerene cone structure of the HIV-1 capsid. They identify a hexamer/pentamer switch that allows for cone assembly and modulates the ligand-binding properties of the capsid.
Main
Upon entry into a new host cell, the HIV-1 capsid performs several essential functions, including shielding the genome from innate immune sensors1, promoting reverse transcription2 and transporting the core from the entry site at the plasma membrane to the integration site inside the nucleus3,4. The fullerene cone architecture of the HIV-1 capsid represents an extreme case of quasi-equivalence, in which essentially each of the 1,200 or more copies of the assembled viral CA protein occupies a different chemical environment and thus adopts a different structural configuration5–7. Along the body of the cone, the CA subunits are assembled on a hexagonal lattice, with the CA amino-terminal domain (NTD) making hexameric rings that are linked together by the carboxy-terminal domain (CTD). In this part of the capsid, conformational variability afforded by CA’s two-domain organization accounts for quasi-equivalence, which manifests in the continuously changing curvature of the hexagonal lattice along the body of the cone7,8. Twelve CA pentamers occupy sharp points of curvature—termed declinations—exactly 12 of which are required for the capsid to completely close5. The molecular rules that dictate CA hexamer or pentamer formation have not been previously elucidated. In other quasi-equivalent viruses that have been studied, the capacity of genetically identical subunits to form hexamers and pentamers is conferred by molecular switches9,10. Such a switch has not been previously found in retroviral CA proteins. Furthermore, the relative contributions of CA hexamers and pentamers to HIV-1 capsid interactions with host factors in the post-entry pathway are also unknown. To address these key gaps, we performed cryogenic electron microscopy (cryo-EM) and biochemical analyses of pentamer-containing in vitro capsids and their complexes with ligands that modulate HIV-1 capsid assembly, stability and function.
Results
Assembly and structural analysis of in vitro HIV-1 capsids
The classic in vitro model system for the HIV-1 capsid is tubular capsid-like particles (CLPs), which assemble when purified HIV-1 CA protein is incubated in high salt concentrations (≥1 M NaCl) and basic pH6,11. These tubes are made only of CA hexamers. Recently, the cellular metabolite inositol hexakisphosphate (IP6) has been shown to stabilize the HIV-1 capsid, by binding to the central channel of the CA hexamer12,13. IP6 also induces assembly of CA in vitro, even at physiological salt conditions12. We found that IP6-induced CLPs have a range of morphologies—capped tubes and cones—when assembled at pH 8, but are primarily conical at pH 6 (Extended Data Fig. 1). These observations indicate that IP6 promotes incorporation of CA pentamers into the assembling lattice, allowing formation of declinations that close the capsid shell. Low pH, in itself, does not efficiently induce CA pentamer formation in vitro11,14, but rather potentiates IP6’s ability to form these pentamers.
By adapting deep two-dimensional (2D) classification particle selection15 and lattice-mediated alignment strategies16, we determined the structure of the declination from projection images of the IP6-induced conical CLPs (Fig. 1a,b, Extended Data Fig. 2, and Table 1). Local refinement with imposed fivefold symmetry resulted in a high-quality map at a nominal resolution of 3.4 Å, in which the central pentamer and surrounding hexamers are well-defined (Fig. 1c, Extended Data Fig. 2d, and Supplementary Video 1). Both the pentamer (Fig. 1d) and hexamer (Fig. 1e) are similar to their corresponding lower-resolution in situ structures that were determined by sub-tomogram averaging of capsids in intact virions7,17 (Extended Data Fig. 3). This indicates that the conical IP6-induced HIV-1 CA assemblies more closely mimic the architecture of the HIV-1 capsid than do previously described in vitro model systems.
Table 1.
WT declination | WT declination + CPSF6-FG | T = 1 (CA-G60A G61P) | T = 1 (CA-M66A) | T = 1 (CA-G60A G61P M66A) | ||
---|---|---|---|---|---|---|
EMDB | EMD-26715 | EMD-28186 | EMD-28054 | EMD-28057 | EMD-26718 | |
PDB | 7URN | 8EJL | 8EEP | 8EET | 7URT | |
Data collection, processing and map calculation | ||||||
Magnification | ×81,000 | ×81,000 | ×81,000 | ×92,000 | ×81,000 | |
Voltage (kV) | 300 | 300 | 300 | 200 | 300 | |
Electron exposure (e–/Å2) | 50 | 54 | 50 | 48 | 50 | |
Defocus range (μm) | 0.5 to 2.5 | 0.75 to 2.5 | 0.5 to 2.5 | 0.5 to 2.5 | 0.5 to 2.5 | |
Pixel size (Å) | 1.08 | 1.08 | 1.08 | 0.75 | 1.08 | |
Symmetry imposed | C5 | C5 | I | I | I | |
Particles | 525,219 | 166,463 | 494,057 | 116,627 | 509,666 | |
Map resolution (Å) | 3.4 | 3.9 | 2.2 | 3.1 | 2.4 | |
FSC threshold | 0.143 | 0.143 | 0.143 | 0.143 | 0.143 | |
Map resolution range (Å) | 2.3–8.3 | 2.5–8.9 | 2.2–4.9 | 2.1–7.2 | 2.4–5.2 | |
Coordinate modeling and refinement | ||||||
Chain A (pentamer) | Chains L,M,N (half-hexamer) | |||||
Initial model | PDB 4XFX | PDB 4XFX | PDB 7URN | PDB 7URT | PDB 7URT | PDB 4XFX |
Model resolution (Å) | 3.4 | 3.6 | 4.1 | 2.5 | 3.4 | 2.5 |
FSC threshold | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Map sharpening B-factor (Å2) | 146.9 | 146.9 | 159.3 | 97.0 | 144.4 | 109.7 |
Model composition | ||||||
Non-hydrogen atoms | 1,725 | 5,175 | 4,431 | 1,726 | 1,726 | 1,726 |
Protein residues | 221 | 663 | 619 | 221 | 221 | 221 |
IP6 | 2 | 0 | 0 | 2 | 2 | 2 |
B-factors (Å2) | 73.2 | 78.8 | 117.0 | 42.9 | 42.6 | |
Root mean squared deviations | ||||||
Bond lengths (Å) | 0.006 | 0.004 | 0.005 | 0.002 | 0.004 | 0.004 |
Bond angles (°) | 0.623 | 0.508 | 0.545 | 0.647 | 1.019 | 0.554 |
Validation | ||||||
MolProbity score | 1.57 | 1.42 | 1.81 | 1.33 | 1.37 | 1.34 |
Clash score | 8.40 | 5.79 | 7.23 | 3.95 | 6.23 | 4.05 |
Poor rotamers (%) | 0.43 | 1.24 | 3.04 | 1.59 | 1.07 | 1.60 |
Ramachandran plot | ||||||
Favored (%) | 97.26 | 97.87 | 97.82 | 100 | 99.54 | 99.09 |
Outliers (%) | 0 | 0 | 0 | 0 | 0 | 0 |
Z-score | 1.00 | 1.79 | 1.74 | 1.98 | 1.87 | 1.22 |
IP6 stabilizes the pentameric HIV-1 CA ring
Both the hexamer and pentamer contain two IP6 molecules inside their central channels, one above and one below the ring of positively charged Arg18 side chains; the lower IP6 molecules are also coordinated by a second ring of Lys25 side chains (Fig. 1f). These support the model that charge neutralization promotes formation of the hexamer and pentamer. However, removal of the charges has different effects on CA assembly in vitro. Whereas the R18A substitution abolishes IP6-dependent assembly of CA altogether12, the K25A mutant is able to assemble tubes18. These observations suggest that Arg18 interactions stabilize both the hexamer and pentamer, whereas Lys25 interactions are more important for the pentamer. Consistent with this interpretation, the pentamer channel is narrower at the position of the Lys25 ring (dashed circles in Fig. 1f), allowing close, direct contacts between the primary amines of the lysine side chains and the phosphates of the lower IP6 molecule. Thus, our structure indicates that IP6 contacts with Arg18 also directly stabilize the CA hexamer, and contacts with both Arg18 and Lys25 stabilize the pentamer.
Quasi-equivalence of the HIV-1 CA hexamer and pentamer
In quasi-equivalent assembly systems, formation of different oligomers by the same protein is controlled by a conformational switch, which adopts different configurations that are evident from comparison of high-resolution structures of the quasi-equivalent states19. Superposition of the HIV-1 CA subunits in the hexamer and pentamer (Fig. 2a,b) allowed us to identify a putative switch in the NTD, comprising a Thr58-Val59-Gly60-Gly61 (TVGG) motif that adopts two alternative configurations—random coil in the hexamer, and 310 helix in the pentamer (Fig. 2c). These configurations are well-defined in our cryo-EM map (Extended Data Fig. 4a–d and Supplementary Video 2). The interpretation that the TVGG motif functions as a switch is supported by its structural context: the motif mediates alternative packing of the NTD–NTD and NTD–CTD interfaces that hold together the capsomers (Fig. 2d,g,j).
In the hexamer, the NTD–NTD interface consists of a 3-helix repeating unit (helix 2 of one subunit and helices 1 and 3 of the adjacent subunit) that makes an 18-helix barrel (Fig. 2e). In the pentamer, helix 3 is excluded from the repeating unit, which then makes a ten-helix barrel (Fig. 2f). Refolding of the TVGG motif facilitates switching from the three-helix to the two-helix unit through a ratcheting mechanism. In the hexamer, Thr58 and Asn57 are the C-terminal residues of helix 3 and engage in reciprocal knobs-in-holes packing against Pro38 and Met39 in helix 2 of the neighboring subunit (Fig. 2e, boxed). In the pentamer, the protein backbone overwinds at Thr58 to facilitate the α-to-310 helix transition (Fig. 2f, boxed). The conformational change disfavors the knobs-in-holes packing of helices 2 and 3, and instead Pro38-Met39 packs against Val24-Lys25 in helix 1. Thus, analogous to the ‘pawl’ of a ratchet, Pro38-Met39 in helix 2 engages two alternative ‘gears’: Asn57-Thr58 in helix 3 to form the hexameric NTD–NTD interface, or Val24-Lys25 in helix 1 to form the pentameric interface (Fig. 2g). Refolding of the TVGG motif toggles alternative packing by remodeling the hexamer gear, allowing the pawl to ‘slip’ into the pentamer state (Fig. 2h).
The TVGG motif also mediates alternative packing of the NTD–CTD interface (Fig. 2i–k). In the hexamer, helix 8 of the CTD is adjacent to the helix 3–helix 4 loop (Fig. 2i). The highly conserved Arg173 residue in this helix makes two hydrogen bonds (green in Fig. 2i): one that caps the C-terminal end of helix 3 (Asn57) and another to the carbonyl of Val59. These are part of an extensive hydrogen-bonding network (Extended Data Fig. 5a) that facilitates pivoting of the CTD to accommodate the variable curvature of the hexagonal capsid lattice, as we have previously shown20. Our results suggest that the hydrogen-bonding network has an additional function in stabilizing both the random coil configuration of the switch and the α-helical character of helix 3. In the pentamer, the helix 3–helix 4 loop with the 310 helix configuration no longer interacts with helix 8 owing to repositioning of the CTD (Fig. 2j). Instead, Arg173 makes hydrogen bonds (green in Fig. 2j) with a different partner (Glu28) in helix 1. Also, the C-terminal end of helix 7 (NTD) and portions of the NTD–CTD linker pack against the groove between helices 8 and 11 (CTD) (Extended Data Fig. 5a).
In summary, the TVGG motif within the helix 3–helix 4 loop of HIV-1 CA adopts two distinct secondary structural folds—random coil and 310 helix—each of which engages a distinct set of quaternary packing interactions in the hexamer and pentamer. The location of the motif allows it to simultaneously modulate both the NTD–NTD and NTD–CTD interfaces (Fig. 2d,g,k), explaining how these two sets of interactions cooperate during capsid assembly.
The TVGG motif remodels the hydrophobic core of the NTD
Refolding of the TVGG loop moves these four residues towards the protein hydrophobic core, and thereby changes or remodels the core. A large hidden pocket in the hexameric NTD core becomes smaller in the pentamer because the empty space is partly occupied by the repositioned Val59 side chain (Extended Data Fig. 5b). Proximal to the TVGG motif, Met66 changes its rotamer configuration to function as a gate (Fig. 2c). In the hexamer state, the Met66 gate is partly buried in the hydrophobic core in a ‘closed’ configuration and becomes exposed in an ‘open’ configuration to avoid clashing with the folded 310 helix in the pentamer state. More distal to the TVGG motif, the Ala31-Phe32 peptide bond in the helix 1–helix 2 loop rotates by ~180° relative to the hexamer (Extended Data Fig. 5c). The Phe32 side chain points towards the hydrophobic core of the protein and lines the hidden pocket in both states. We propose that these conformational changes are functionally linked, and identify an allosteric network that communicates IP6-mediated interactions in helices 1 and 2 (NTD–NTD interface) to the TVGG switch.
Importance of the TVGG motif and associated elements
All of the residues identified above are important for viral replication or inhibition. Substitutions for Val59 and Gly60 within the TVGG motif result in non-viable or severely impaired viruses21–24. Mutations in the Pro38-Met39 pawl in helix 2 abolish CA assembly25 or drastically lower the intrinsic stability of the capsid26,27. Asn57 and the Met66 gate modulate binding of the assembled capsid to host factors that are important for nuclear import and integration, as well as binding to one class of capsid-targeting inhibitors28–37. The hidden pocket in the NTD core that is walled by Phe32 and Val59 is also a binding site for a different class of inhibitors21,38. Thr58 and Met66 mutations and polymorphisms confer drug resistance, although at severe costs to viral fitness21,34–36. Thus, the TVGG motif is positioned at a critical site for capsid function and inhibition, indicating that it may have post-assembly functions as well.
Designed manipulations of the CA hexamer/pentamer switch
To test our hypothesis that the TVGG motif is a molecular switch, we designed structure-based mutations to control the coil/helix configuration, which should predict the in vitro assembly behavior of the CA protein and resulting CLP morphology (Fig. 3a). Solution conditions can also affect CLP morphology (Extended Data Fig. 1a–c), so for comparative analysis we used the IP6-induced conditions at pH 6, which produced conical CLPs with wild-type (WT) CA (Fig. 3b and Extended Data Fig. 1c).
WT HIV-1 CA is known to favor hexamer formation in vitro, implying that the 310 helix configuration of the TVGG motif is normally disfavored. To stabilize the 310 helix and thus favor the pentamer, we replaced the two glycines in the TVGG motif with alanine and proline. Crude modeling indicated that these two substitutions are compatible with the backbone configuration of the dipeptide in the pentamer state, but not the hexamer state. Indeed, incubation of CA-G60A G61P with IP6 induced assembly of small spheres of around 20 nm in diameter (Fig. 3c and Extended Data Fig. 1d). Cryo-EM imaging indicated that the spheres are T = 1 particles, or icosahedra made of 12 pentamers and no hexamers (Fig. 3f). Next, we surmised that the Met66 gate must constitute part of the activation barrier for coil-to-helix switching. Thus, a constitutively open gate (M66A) should also favor pentamers, and indeed the CA-M66A mutant also assembled into T = 1 particles (Extended Data Fig. 1e), as did the CA-G60A G61P M66A triple mutant (Extended Data Fig. 1f). We solved the cryo-EM structures of these T = 1 capsids to 2.2 Å (CA-G60A G61P), 3.1 Å (CA-M66A), and 2.4 Å (CA-G60A G61P M66A) (Fig. 3f, Extended Data Fig. 6 and Table 1). These confirmed that the mutant pentamers have the same structure as the WT pentamer, with the switch in the 310 helix configuration and the gate in the open configuration (Extended Data Fig. 4e–g).
We then asked whether the CA mutants can still form hexamers by assembling them in 1 M NaCl and pH 8 conditions, in which WT CA assembles only open tubes (Extended Data Fig. 1a). CA-G60A G61P formed only aggregates, supporting the interpretation that the mutations locked the protein in its pentamer state (Extended Data Fig. 1d,f). Interestingly, the CA-M66A mutant also failed to assemble in three independent experiments (Extended Data Fig. 1e), although the mutation does not directly modify the TVGG switch. This result argues against a simple model wherein the TVGG motif fluctuates between the two states pre-assembly and then gets locked in upon assembly. We speculate that the random coil configuration may be analogous to a restrained spring that is poised to refold but is prevented from doing so by the closed Met66 gate.
We were unable to identify amino acid substitutions to rigidify the random coil configuration of the TVGG switch, which we predicted would have locked CA in its hexamer state. Nevertheless, structure-based mutations can be introduced to disfavor switching into the pentamer. As described above, Val24 stabilizes the pentameric NTD ring by mediating the knobs-in-holes interaction of helices 1 and 2 (Fig. 3d). Accordingly, the V24D mutation favored assembly of long, tubular CLPs when incubated with IP6 at pH 6 (Fig. 3d and Extended Data Fig. 1g,l).
Finally, we tested modifications to the protein hydrophobic core and its potential allosteric role in hexamer/pentamer switching. We predicted that increasing the packing density of the core would inhibit core remodeling and pentamer formation. To achieve this without modifying the TVGG motif, we replaced Leu138 with larger side chains; this residue is in helix 7, across the internal pocket from Val59, and does not directly interact with the switch (Extended Data Fig. 5b). The L138F, L138W and L138Y mutations significantly destabilized CA, yet the L138F and L138W mutants could still form cones. However, the CLPs were generally longer than the WT, indicative of impaired pentamer formation (Fig. 3d,e and Extended Data Fig. 1h–i,l). L138F also resulted in very long (>1 μm) tubes. Although there were fewer of these tubes, each contains tens of thousands of CA subunits in the hexamer state, again indicative of a lower propensity to form pentamers. We also tested the importance of the conformational change in the helix 1–helix 2 loop involving Ala31 and Phe32 (Extended Data Fig. 5c). As with the Leu138 substitutions, A31G and F32A also destabilized the protein and reduced assembly efficiency, yet still supported cone formation. The F32A mutation led to a higher proportion of tubular capsids, again indicating that pentamer formation is disfavored (Extended Data Fig. 1j–l). These results support the idea that the protein hydrophobic core allosterically connects helix 1, where IP6 binds, and the TVGG switch.
The HIV-1 CA hexamer/pentamer switch modulates ligand binding
One of the critical functions of the HIV-1 capsid is to recruit host cell factors that promote viral replication in terminally differentiated T cells and macrophages, the natural hosts of HIV-1. Because these interactions are typically studied biochemically and structurally in context of the HIV-1 CA hexamer, and because genetic approaches cannot distinguish between the hexamer and pentamer, any potential contributions from the pentamer have been unknown. A major class of such capsid-binding factors includes CPSF6, NUP153 and SEC24C, each of which contains one or more phenylalanine-glycine (FG) motifs that bind within the NTD–CTD interface of the hexamer29–31,33,37,39,40. Binding of these natural FG ligands is competitively inhibited by the pharmacological inhibitors PF74 (refs. 30–32,40) and GS-CA1/GS-6207/lenacapavir34–36, each of which contains an analogous phenyl ring. The FG-motif phenylalanine ring binds to a hydrophobic pocket on the surface of the NTD that is adjacent to the helix 3–helix 4 loop containing the TVGG switch (Fig. 4a,c). This NTD pocket alone is sufficient for weak binding28,29,40. Tighter binding is afforded by additional contacts with the CTD, which adopts a closed configuration and contacts ligand moieties outside of the phenyl ring30,31. In essence, the NTD pocket makes the basal interaction with the FG motif or its equivalent (μM affinity), whereas surrounding elements contribute to tighter binding (pM for lenacapavir35).
Our structures indicate that the alternative configurations of the TVGG motif remodel the NTD pocket (compare Fig. 4a and Fig. 4b). Furthermore, superpositions with published structures of CA in complex with FG-motif peptides indicate that the closed-gate configuration of Met66 in the hexamer is compatible with binding (Fig. 4c), but the open-gate configuration moves the Met66 side chain into the phenylalanine pocket, causing a steric clash with the ligand’s phenyl ring (Fig. 4d). Thus, the CA pentamer should be impaired in binding FG motifs. To assess whether pentamers and hexamers have different FG-binding properties, we measured the thermostability of the CLPs in the presence or absence of a representative FG-motif ligand, a peptide derived from the host factor CPSF6 (refs. 29–31) (Fig. 4e and Extended Data Fig. 7). To ensure that all signals come from assembled CA, CLPs were first purified from unassembled protein and aggregates by using size-exclusion chromatography. In accordance with our prediction, the CA-M66A, CA-G60A G61P and CA-G60A G61P M66A T = 1 particles were not stabilized by the FG peptide. In contrast, WT CLPs were stabilized by FG peptide, but not by a negative control GG peptide in which the FG phenylalanine was replaced by glycine. These results indicate that CLP binding to FG motifs requires the CA hexamer and that the CA-mutant pentamers lost binding, but do not rule out the formal possibility that WT CA pentamers can still bind FG.
Because bulk biochemical assays cannot distinguish between pentamers and hexamers in WT CLPs, we assayed for differential binding using cryo-EM. We incubated the WT CLPs at high concentration (0.27 mM CA) with 11-fold excess FG peptide to ensure saturation of available binding sites. Images of the complexes were collected for two independent samples, and then structures (6.0- and 6.3-Å resolution) of the declinations were solved, imposing no symmetry and using a large box size that encompassed 1 pentamer and 17 hexamers (Extended Data Fig. 8a,b). The hexamers serve as an internal positive control, and indeed bound peptides were clearly seen as U-shaped densities within all of the resolved hexameric NTD–CTD interfaces (Extended Data Fig. 9). To visualize the detailed interactions, we refined one data set to 3.9-Å nominal resolution (Fig. 4f–h, Extended Data Fig. 8b and Table 1). The FG peptide bound in the expected configuration to the hexamers (Fig. 4f), with the FG phenylalanine and CA Met66 side chains clearly resolved by the map (Fig. 4g). We did not find peptide densities within the pentameric NTD–CTD interfaces (Fig. 4h and Extended Data Fig. 9). We therefore conclude that the CA pentamer does not bind to the CPSF6-FG motif and, by extension, is unlikely to bind other FG-containing host factors, such as NUP153 or SEC24C.
Discussion
Here, we identify the conformational switch that modulates the ability of the HIV-1 CA protein to generate the hexameric and pentameric capsomers in the viral capsid. In other virus capsid proteins, amino and carboxyl termini are well-characterized switches that typically undergo order/disorder transitions9,10,41,42. The CA termini also function as order/disorder switches that are triggered by programmed proteolysis43,44, but these modulate conversion of the immature capsid into the mature capsid and not hexamer/pentamer switching. The TVGG motif in CA is distinct from these known switches because it is an internal loop that refolds from one ordered configuration to another.
Although the exact trigger of the TVGG switch within virions remains to be established, our in vitro assembly data indicate that IP6 can perform this function. This is in line with other viral capsid switches, which are also sensitive to the assembly environment9. IP6 binds CA helix 1 at the central channels of the hexamer and pentamer, and so must trigger the TVGG switch through allostery, again a common theme in virus capsid assembly19,45. In principle, allostery between IP6 and the TVGG switch can occur as the NTD–NTD and NTD–CTD interactions cooperatively form during assembly. Interestingly, however, our data indicate that allosteric communication may run through the protein hydrophobic core. Specifically, we find that: (1) refolding of the TVGG motif also remodels the core, (2) the helix 1–helix 2 loop changes conformation, (3) this loop includes Phe32, whose side chain is buried in the core, and (4) CA mutations that alter the core retain assembly but impair switching. These observations support the idea that the TVGG motif is allosterically connected to helix 1 by the hydrophobic core. A similar phenomenon has been documented in protein kinases, in which core residues act as a non-covalent bridge between two elements (called ‘splines’) located on opposite sides of the protein fold46. We speculate that CA’s helix 1–helix 2 (NTD–NTD interface) and helix 3–helix 4 (NTD–NTD and NTD–CTD interfaces) are analogous ‘splines’ bridged by the residues that line its loosely packed hydrophobic core. Allostery in kinases has been successfully exploited for pharmacological inhibition47,48, and similar strategies may also be applicable to HIV-1 CA.
Another important insight from these studies is our discovery that the HIV-1 CA hexamer/pentamer switch modulates not just the assembly process, but also the capacity of the assembled capsid to bind FG-motif host cell factors that are important for the post-entry pathway of the virus. Our results suggest that CPSF6 and other FG-motif host cell factors, which are implicated in HIV-1 nuclear import and integration site selection49, bind only to the hexamer. Other studies indicate that pentamer-specific factors might facilitate core trafficking in the cytoplasm or docking to the nucleus3,50, pointing to division of labor between the two capsomers. Taken together, these observations support the requirement for an intact or nearly intact capsid at these viral replication steps.
Lenacapavir, a new ultra-potent HIV-1 inhibitor, binds to the same site on the capsid as FG motifs. Indeed, a single point mutation in the methionine gate (M66I) confers resistance to this drug, although at severe cost to viral fitness35,36. The molecular basis of this fitness cost can now be explained in light of our findings.
Methods
Protein purification and assembly
HIV-1 CA proteins were purified as has been described51. Conical CLPs were assembled by incubating the protein (12–20 mg/mL) in 4–5 mM IP6, 50 mM MES, pH 6, 150 mM NaCl, 5 mM β-mercaptoethanol at 37 °C for 1–2 hours. Tubular CLPs were assembled by incubating the protein in 50 mM Tris, pH 8, 1 M NaCl, 5 mM β-mercaptoethanol at 37 °C for 1–2 hours. CA mutants were purified and assembled in the same way as the WT protein. Peptide-bound WT CLPs were prepared by diluting assembled CA (0.54 mM in 4 mM IP6) twofold into buffer containing 3 mM CPSF6-FG peptide (GTPVLFPGQPFGQPPLG, N-terminally acetylated and C-terminally amidated; Celltein), followed by incubation for 30 minutes on ice.
Cryo-EM structure determination
Conical CLPs (with or without bound FG peptide) were diluted 8- to 12-fold with 25 mM MES, pH 6, 100 μM IP6 and then immediately applied (4 μL) to glow-discharged lacey carbon 300-mesh Cu grids. T = 1 particles were purified from unassembled protein using size-exclusion chromatography (Superdex 200 10/300 GL; Cytiva) in 25 mM MES, pH 6, 50 mM NaCl, 10 mM β-mercaptoethanol, 100 μM IP6, and 4 μL of relevant fractions were applied to C-flat 1.2/1.3 300-mesh holey carbon grids. Grids were briefly blotted manually and plunge-frozen in liquid ethane using a home-built device.
Cryo-EM data were collected at the University of Virginia Molecular Electron Microscopy Core. For the WT CLPs, CA-G60A G61P T = 1 particles, and CA-G60A G61P M66A particles, videos were collected using a Krios (ThermoFisher) operating at 300 kV and equipped with an energy filter and K3 direct detector (Gatan). Data were collected using EPU (ThermoFisher) at a pixel size of 1.08 Å in counting mode, with a total dose of 50 electrons/Å2 over 40 frames and target defocus of −0.5 to −2.5 μm. For CA-M66A T = 1 particles, videos were collected using a Glacios (ThermoFisher) operating at 200 kV and equipped with a Falcon 4 detector (ThermoFisher), at a pixel size of 1.5 Å in superresolution mode (effective pixel size of 0.75 Å), with a total dose of 48 electrons/Å2. For CPSF6-bound CLPs, we collected two data sets using the Krios on two independent samples: sample 1, at a pixel size of 1.62 Å and total dose of 54 electrons/Å2, and sample 2, at 1.08 Å and 50 electrons/Å2.
All image processing and map calculations were performed in cryoSPARC v.3.3.1–3 (ref. 52) (Table 1). Raw movies were corrected for beam-induced motion using MotionCor2 (ref. 53), and CTF estimation was performed with CTFFIND4 (ref. 54), as implemented in cryoSPARC. Initial particles were manually picked to generate references for subsequent template-based picking.
For the WT CA declination structure, 13,439,772 particles were initially extracted in box size 924 px (998 Å) (Extended Data Fig. 2a). Two rounds of reference-free 2D classification and selection were performed to identify and remove junk particles (mostly carbon edges) (Extended Data Fig. 2b). The selected 3,985,778 particles were then re-extracted in box size 616 px (665 Å) and processed through several rounds of iterative reference-free 2D classification and selection (Extended Data Fig. 2c). Parameters were adjusted with the goal of having well-defined classes, each with around 500–5,000 particles in the final round. This resulted in 1,345,054 particles that were used for ab initio structure calculation (5 models, C1 symmetry). Four models (1,075,923 particles) converged on similar maps and were combined into a single particle set through one round of refinement with C1 symmetry and a low-pass filter of 20 Å. The resulting map was then rotated and centered on the pentamer. Heterogeneous refinement (3D classification, 2 models) was then performed in C1, with a low-pass filter of 20 Å. After discarding overlaps, the final set of 525,219 particles was re-extracted in box size 308 px (333 Å) and refined with C5 symmetry and local CTF estimation, resulting in a map at a nominal resolution of 3.4 Å (Extended Data Fig. 2d).
For the T = 1 icosahedra, 503,025 (CA-M66A), 1,513,851 (CA-G60A G61P), and 694,288 (CA-G60A G61P M66A) particles were extracted (Extended Data Fig. 6). After two or three rounds of reference-free 2D classification, 116,627 (CA-M66A), 494,057 (CA-G60A G61P), and 509,666 (CA-G60A G61P M66A) particles were used for ab initio calculation with I symmetry imposed. Homogeneous refinement resulted in final maps at nominal resolutions of 3.1 Å (CA-M66A), 2.2 Å (CA-G60A G61P), and 2.4 Å (CA-G61A G61P M66A) (Extended Data Fig. 4e–g).
For the low-resolution FG peptide-bound structures, the particle sets after junk removal and 2D classification were processed through one round of heterogeneous refinement (using as reference two copies of a WT map filtered to 20 Å) (Extended Data Fig. 8). For sample 1, further alignment of 314,487 particles with C1 symmetry and box size 400 px (648 Å) produced a map at ~6.3-Å resolution (Extended Data Fig. 8c). For sample 2, alignment of 320,258 particles with C1 symmetry and box size 616 px (665 Å) produced a map at ~6.0-Å resolution (Extended Data Fig. 8d). Sample 2 was then reprocessed through another round of heterogeneous refinement to obtain a final set of 166,463 particles (box size 308 px, 333 Å), which was then refined with C5 symmetry to a nominal resolution of 3.9 Å (Extended Data Fig. 3e).
Model building and refinement
Coordinate models were built for the WT declination by docking PDB 4XFX (ref. 32) into the maps, followed by iterative manual rebuilding using Coot55 and real-space refinement using Phenix56 (phenix.real_space_refine). Refinements were performed separately for two groups: the pentamer subunit (chain A) and the three closest hexamer subunits to the pentamer (chains L, M, and N) (Table 1). Non-crystallographic symmetry restraints were used when appropriate. The remaining hexamer subunits (chains O, P, and Q) were modeled by rigid-body docking of the final refined model of chain M as polyalanine.
Modeling of the WT declination in complex with FG peptide was performed by rigid body docking of chains A, L, M and N of the final refined WT model into the 3.9-Å map. The peptide was initially obtained by docking PDB 4WYM chain M (ref. 31) into the appropriate densities. Real-space refinement was performed as described above.
For the T = 1 particles, one copy of PDB 4XFX was docked into the CA-G60A G61P M66A map, followed by iterative manual rebuilding and real-space refinement. One round of morphing was performed in the first refinement iteration. To obtain CA-M66A and CA-G60A G61P models, the final refined model of the triple mutant was fitted through one round of rigid-body refinement. The mutated regions were rebuilt and refit manually, and then the models were subjected to two or three rounds of real-space refinement.
In all maps, modeling of IP6 densities was restricted to rigid-body fitting of the myo isoform, as described previously12.
Figures were made with Chimera or MacPyMOL (Delaglio Scientific).
Negative-stain EM
Samples (4 μL) were applied to Formvar continuous carbon 300-mesh Cu grids and incubated for 2 minutes. Grids were moved to a 20-μL drop of 0.1 M KCl, incubated for 2 minutes and blotted. Grids were then placed on a 20-μL drop of 2% uranyl acetate, incubated for 2 minutes and blotted until they were dry. Images were collected on a Tecnai Spirit (ThermoFisher) or an F20 microscope (ThermoFisher), both operating at 120 kV.
Nanodifferential scanning fluorimetry
Thermostabilization assays were performed using CLPs purified through size exclusion in 20 mM Tris, pH 8, 50 mM NaCl, 40 μM IP6. CLPs were diluted in the same buffer (to final μM concentrations as indicated) containing FG peptide (500 μM), GG peptide (500 μM) or no peptide. Samples were incubated for 5 minutes, then analyzed using a Tycho NT.6 (NanoTemper). Apparent melting temperatures were determined from raw curves using the manufacturer’s software.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Online content
Any methods, additional references, Nature Portfolio reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41594-022-00913-5.
Supplementary information
Acknowledgements
Transmission electron micrographs were recorded at the University of Virginia Molecular Electron Microscopy Core facility (RRID: SCR_019031), which was built in part with NIH grant G20-RR31199. Purchase of the Krios was funded in part by S10-RR025067. This study was funded by R21-AI167756, P50-AI150464 and U54-AI170856 (O. P. and B. K. G.-P.). R. T. S. was supported by T32-GM008136. We especially thank K. Dryden and M. Purdy for invaluable assistance in EM data collection and processing, and M. Purdy for help with optimizing server and software set up.
Extended data
Source data
Author contributions
Cloning, mutagenesis, protein purification and assembly: R. T. S., N. F. B. d. S., K. K. Z, I. K. Negative stain EM: R. T. S., N. F. B. d. S., B. K. G.-P. Cryo-EM sample preparation and data collection: R. T. S., N. F. B. d. S., B. K. G.-P. Image data processing: R. T. S., B. K. G.-P., O. P. Coordinate modeling and refinement: R. T. S., O. P. Project conceptualization and funding acquisition: B. K. G.-P. and O. P. Protocol design and development: R. T. S., N. F. B. d. S., I. K., B. K. G.-P., O. P. Manuscript preparation: O. P. with input from all authors.
Peer review
Peer review information
Nature Structural & Molecular Biology thanks Alan Engelman and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editors: Florian Ullrich, Katarzyna Ciazynska and Carolina Perdigoto, in collaboration with the Nature Structural & Molecular Biology team.
Data availability
Cryo-EM maps have beeb deposited at the Electron Microscopy Data Bank (EMDB) under accession numbers EMD-26715 (WT declination), EMD-28054 (T = 1 CA-G60A G61P), EMD-28057 (T = 1 CA-M66A), EMD-26718 (T = 1 CA-G60A G61P M66A) and EMD-28186 (WT declination bound to CPSF6-FG peptide). Coordinates have been deposited at the Protein Data Bank (PDB) under accession numbers 7URN (WT declination), 8EJL (WT–FG complex), 8EEP (CA-G61A G60P), 8EET (CA-M66A) and 7URT (CA-G60A G61P M66A). The following datasets were used in this study: EMD-3465, EMD-3466, PDB 5MCY, PDB 4XFX, PDB 3H47, PDB 4WYM, PDB 5TSX and PDB 6PU1. Source data are provided with this paper.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Randall T. Schirra, Nayara F. B. dos Santos.
Contributor Information
Barbie K. Ganser-Pornillos, Email: bpornillos@virginia.edu
Owen Pornillos, Email: opornillos@virginia.edu.
Extended data
is available for this paper at 10.1038/s41594-022-00913-5.
Supplementary information
The online version contains supplementary material available at 10.1038/s41594-022-00913-5.
References
- 1.Hilditch L, Towers GJ. A model for cofactor use during HIV-1 reverse transcription and nuclear entry. Curr. Opin. Virol. 2014;4:32–36. doi: 10.1016/j.coviro.2013.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Christensen DE, Ganser-Pornillos BK, Johnson JS, Pornillos O, Sundquist WI. Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro. Science. 2020;370:abc8420. doi: 10.1126/science.abc8420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Zila V, Müller TG, Müller B, Kräusslich HG. HIV-1 capsid is the key orchestrator of early viral replication. PLoS Pathog. 2021;17:e1010109. doi: 10.1371/journal.ppat.1010109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Naghavi MH. HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection. Retrovirology. 2021;18:19. doi: 10.1186/s12977-021-00563-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. Assembly and analysis of conical models for the HIV-1 core. Science. 1999;283:80–83. doi: 10.1126/science.283.5398.80. [DOI] [PubMed] [Google Scholar]
- 6.Li S, Hill CP, Sundquist WI, Finch JT. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature. 2000;407:409–413. doi: 10.1038/35030177. [DOI] [PubMed] [Google Scholar]
- 7.Mattei S, Glass B, Hagen WJ, Kräusslich HG, Briggs JA. The structure and flexibility of conical HIV-1 capsids determined within intact virions. Science. 2016;354:1434–1437. doi: 10.1126/science.aah4972. [DOI] [PubMed] [Google Scholar]
- 8.Pornillos O, Ganser-Pornillos BK, Yeager M. Atomic-level modelling of the HIV capsid. Nature. 2011;469:424–427. doi: 10.1038/nature09640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Johnson JE, Speir JA. Quasi-equivalent viruses: a paradigm for protein assemblies. J. Mol. Biol. 1997;269:665–675. doi: 10.1006/jmbi.1997.1068. [DOI] [PubMed] [Google Scholar]
- 10.Dokland T. Freedom and restraint: themes in virus capsid assembly. Structure. 2000;8:R157–R162. doi: 10.1016/S0969-2126(00)00181-7. [DOI] [PubMed] [Google Scholar]
- 11.Ehrlich LS, Agresta BE, Carter CA. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 1992;66:4874–4883. doi: 10.1128/jvi.66.8.4874-4883.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dick RA, et al. Inositol phosphates are assembly co-factors for HIV-1. Nature. 2018;560:509–512. doi: 10.1038/s41586-018-0396-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mallery DL, et al. IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis. eLife. 2018;7:e35335. doi: 10.7554/eLife.35335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Barklis E, et al. Characterization of the in vitro HIV-1 capsid assembly pathway. J. Mol. Biol. 2009;387:376–389. doi: 10.1016/j.jmb.2009.01.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Yao X, Fan X, Yan N. Cryo-EM analysis of a membrane protein embedded in the liposome. Proc. Natl Acad. Sci. USA. 2020;117:18497–18503. doi: 10.1073/pnas.2009385117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Briggs JA, et al. Structure and assembly of immature HIV. Proc. Natl Acad. Sci. USA. 2009;106:11090–11095. doi: 10.1073/pnas.0903535106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ni T, et al. Structure of native HIV-1 cores and their interactions with IP6 and CypA. Sci. Adv. 2021;7:eabj5715. doi: 10.1126/sciadv.abj5715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Renner N, et al. A lysine ring in HIV capsid pores coordinates IP6 to drive mature capsid assembly. PLoS Pathog. 2021;17:e1009164. doi: 10.1371/journal.ppat.1009164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Domitrovic T, et al. Virus assembly and maturation: auto-regulation through allosteric molecular switches. J. Mol. Biol. 2013;425:1488–1496. doi: 10.1016/j.jmb.2013.02.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pornillos O, et al. X-ray structures of the hexameric building block of the HIV capsid. Cell. 2009;137:1282–1292. doi: 10.1016/j.cell.2009.04.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lemke CT, et al. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein. J. Virol. 2012;86:6643–6655. doi: 10.1128/JVI.00493-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Manocheewa S, Swain JV, Lanxon-Cookson E, Rolland M, Mullins JI. Fitness costs of mutations at the HIV-1 capsid hexamerization interface. PLoS ONE. 2013;8:e66065. doi: 10.1371/journal.pone.0066065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Rihn SJ, et al. Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog. 2013;9:e1003461. doi: 10.1371/journal.ppat.1003461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Al-Mawsawi LQ, et al. High-throughput profiling of point mutations across the HIV-1 genome. Retrovirology. 2014;11:124. doi: 10.1186/s12977-014-0124-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ganser-Pornillos BK, von Schwedler UK, Stray KM, Aiken C, Sundquist WI. Assembly properties of the human immunodeficiency virus type 1 CA protein. J. Virol. 2004;78:2545–2552. doi: 10.1128/JVI.78.5.2545-2552.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Forshey BM, von Schwedler U, Sundquist WI, Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 2002;76:5667–5677. doi: 10.1128/JVI.76.11.5667-5677.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Eschbach JE, et al. Capsid lattice destabilization leads to premature loss of the viral genome and integrase enzyme during HIV-1 infection. J. Virol. 2020;95:00984–20. doi: 10.1128/JVI.00984-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Blair WS, et al. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 2010;6:e1001220. doi: 10.1371/journal.ppat.1001220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Price AJ, et al. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog. 2012;8:e1002896. doi: 10.1371/journal.ppat.1002896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Price AJ, et al. Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly. PLoS Pathog. 2014;10:e1004459. doi: 10.1371/journal.ppat.1004459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bhattacharya A, et al. Structural basis of HIV-1 capsid recognition by PF74 and CPSF6. Proc. Natl Acad. Sci. USA. 2014;111:18625–18630. doi: 10.1073/pnas.1419945112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Gres AT, et al. Structural virology. X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability. Science. 2015;349:99–103. doi: 10.1126/science.aaa5936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Buffone C, et al. Nup153 unlocks the nuclear pore complex for HIV-1 nuclear translocation in nondividing cells. J. Virol. 2018;92:00648–18. doi: 10.1128/JVI.00648-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Yant SR, et al. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model. Nat. Med. 2019;25:1377–1384. doi: 10.1038/s41591-019-0560-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Link JO, et al. Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature. 2020;584:614–618. doi: 10.1038/s41586-020-2443-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Bester SM, et al. Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. Science. 2020;370:360–364. doi: 10.1126/science.abb4808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rebensburg SV, et al. Sec24C is an HIV-1 host dependency factor crucial for virus replication. Nat. Microbiol. 2021;6:435–444. doi: 10.1038/s41564-021-00868-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kelly BN, et al. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J. Mol. Biol. 2007;373:355–366. doi: 10.1016/j.jmb.2007.07.070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lee K, et al. HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6. J. Virol. 2012;86:3851–3860. doi: 10.1128/JVI.06607-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Matreyek KA, Yucel SS, Li X, Engelman A. Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathog. 2013;9:e1003693. doi: 10.1371/journal.ppat.1003693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Barcena J, et al. The coat protein of rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid. Virology. 2004;322:118–134. doi: 10.1016/j.virol.2004.01.021. [DOI] [PubMed] [Google Scholar]
- 42.Luque D, et al. Infectious bursal disease virus capsid assembly and maturation by structural rearrangements of a transient molecular switch. J. Virol. 2007;81:6869–6878. doi: 10.1128/JVI.00077-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.von Schwedler UK, et al. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 1998;17:1555–1568. doi: 10.1093/emboj/17.6.1555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Gross I, et al. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 2000;19:103–113. doi: 10.1093/emboj/19.1.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Zlotnick A, Mukhopadhyay S. Virus assembly, allostery and antivirals. Trends Microbiol. 2011;19:14–23. doi: 10.1016/j.tim.2010.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Kim J, et al. A dynamic hydrophobic core orchestrates allostery in protein kinases. Sci. Adv. 2017;3:e1600663. doi: 10.1126/sciadv.1600663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer. 2009;9:28–39. doi: 10.1038/nrc2559. [DOI] [PubMed] [Google Scholar]
- 48.Dar AC, Shokat KM. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling. Annu. Rev. Biochem. 2011;80:769–795. doi: 10.1146/annurev-biochem-090308-173656. [DOI] [PubMed] [Google Scholar]
- 49.Engelman AN. HIV capsid and integration targeting. Viruses. 2021;13:125. doi: 10.3390/v13010125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Santos da Silva E, et al. HIV-1 capsids mimic a microtubule regulator to coordinate early stages of infection. EMBO J. 2020;39:e104870. doi: 10.15252/embj.2020104870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Yoo S, et al. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 1997;269:780–795. doi: 10.1006/jmbi.1997.1051. [DOI] [PubMed] [Google Scholar]
- 52.Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods. 2017;14:290–296. doi: 10.1038/nmeth.4169. [DOI] [PubMed] [Google Scholar]
- 53.Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331–332. doi: 10.1038/nmeth.4193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216–221. doi: 10.1016/j.jsb.2015.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr. 2010;66:486–501. doi: 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Liebschner D, et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D. Struct. Biol. 2019;75:861–877. doi: 10.1107/S2059798319011471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Briggs JA, et al. The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure. 2006;14:15–20. doi: 10.1016/j.str.2005.09.010. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Cryo-EM maps have beeb deposited at the Electron Microscopy Data Bank (EMDB) under accession numbers EMD-26715 (WT declination), EMD-28054 (T = 1 CA-G60A G61P), EMD-28057 (T = 1 CA-M66A), EMD-26718 (T = 1 CA-G60A G61P M66A) and EMD-28186 (WT declination bound to CPSF6-FG peptide). Coordinates have been deposited at the Protein Data Bank (PDB) under accession numbers 7URN (WT declination), 8EJL (WT–FG complex), 8EEP (CA-G61A G60P), 8EET (CA-M66A) and 7URT (CA-G60A G61P M66A). The following datasets were used in this study: EMD-3465, EMD-3466, PDB 5MCY, PDB 4XFX, PDB 3H47, PDB 4WYM, PDB 5TSX and PDB 6PU1. Source data are provided with this paper.